Komori
Annual Securities Report4524MORISHITA JINTAN CO.,LTD.Pharmaceuticals

Annual Securities Report — FY2025

What MORISHITA JINTAN CO.,LTD. reported for the period from 2025-04-01 to 2026-03-31. Filed by 森下仁丹株式会社

How much it says
52Typical
What moved here
26named for the first time
Its own wording
60terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

For the fiscal year, net sales were ¥12,688 million, operating income was ¥692 million and ordinary income was ¥773 million, representing a year-on-year decline in profit. Investment activities, including the acquisition of property, plant and equipment, resulted in cash flow from investing activities of negative ¥1,232 million.

Komori's summary of this document, not the document's own words.
52Typical
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 38 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
Intensity of Change
68
Detailed
Strategic Shift
49
Typical
Capital Movements
62
Detailed
Disclosure Gaps
0
Almost nothing
Concentration Risk
50
Typical
Future Commitments
68
Detailed
Change in Risk
27
Almost nothing
Financial and Capital Policy
31
Thin
Specificity of Disclosure
53
Typical
Product Portfolio
55
Typical
Technology Position
73
Detailed
Confidence in Strategic Bets
R&D spend11億円Money spent making new things.
Cash left over-82百万円Cash from the business, less what went into equipment.
Spent on equipment5億円Plants, machines — things meant to last.
Employees359Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
MORISHITA JINTAN CO.,LTD. — FY2025 | Komori